Location History:
- Cranberry Township, PA (US) (2004 - 2011)
- Cranberry Twp., PA (US) (2013)
- Gainesville, FL (US) (2013 - 2019)
Company Filing History:
Years Active: 2004-2019
Title: Kirk P Conrad: Innovator in Bone Marrow-Derived Cell Modulation
Introduction
Kirk P Conrad is a notable inventor based in Gainesville, FL (US), recognized for his contributions to the field of biomedical research. He holds a total of 9 patents, showcasing his innovative approaches to medical challenges. His work primarily focuses on the modulation of bone marrow-derived cells, which has significant implications for various therapeutic applications.
Latest Patents
Among his latest patents, one invention titled "Materials and methods for modulating activity of bone marrow derived cells" provides methods for the recruitment of bone marrow-derived endothelial cells (BMDEC) and enhances their function through the administration of relaxin. This invention can be utilized in treating conditions that benefit from the recruitment of these specialized cells. Another significant patent is "Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies." This invention outlines methods to improve a subject's vasculature to normalize maternal hemodynamics, particularly for individuals attempting to conceive via assisted reproductive technologies.
Career Highlights
Kirk P Conrad has had a distinguished career, working with reputable institutions such as the University of Florida Research Foundation and the University of Pittsburgh. His research has contributed to advancements in understanding and utilizing bone marrow-derived cells in medical treatments.
Collaborations
Throughout his career, Kirk has collaborated with esteemed colleagues, including Sanjeev G Shroff and Martyn A Lewis. These collaborations have further enriched his research and innovation in the field.
Conclusion
Kirk P Conrad's work exemplifies the intersection of innovation and medical science, particularly in the modulation of bone marrow-derived cells. His patents reflect a commitment to advancing healthcare solutions and improving patient outcomes.